The opportunity of a lifetime!  The Hope-ICU study is the first clinical effectiveness trial comparing early treatment with haloperidol with placebo in ventilated patients.  Be part of something that is going to have a lasting and significant impact. 

This 30 month project, which has a Research for Patients Benefit grant and is in partnership with the Alzheimer’s Society is based at Watford General Hospital.  You will be a full-time research nurse working with Dr Valerie Page to answer this question - Does haloperidol really make a difference? 

The post will be advertised on the NHS jobs website.  For more information contact Chief Investigator valerie.page@whht.nhs.uk or ICU matron sarah.lafbery@whht.nhs.uk.  What have you got to lose?

The Special Interest Group of the Association of British Neurologists have invited Wes Ely to speak at a focus session at the NCC UK meeting November 12 afternoon to November 13 2010

Sepsis and Delirium in Intensive Care

- Septic Encephalopathy (Robin Howard, Queen Square)

- The UK situation (Valerie Page, Watford)

- Drugs and Delirium in the ICU (Wes Ely, Vanderbilt University, Nashville, USA)

- Neuropsychological sequelae of sepsis and critical illness (Jim Jackson, Vanderbilt University, Nashville, USA)

The meeting fee is £40!!!

For more details contact:   jill.chapman@uhl-tr.nhs.uk